Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Two Oxford Clinical Medical Students place in top 10% in prestigious national Ophthalmology Duke Elder Prize Examination.

Fifth year Clinical Medical student, Mr Rory Maclean (Green Templeton College), gained an impressive sixth place in the Royal College of Ophthalmology's annual Prize Examination.  Mr Maclean was one of 417 medical students from 37 medical schools across the UK and Ireland who took the exam this year. In addition, final year Graduate Entry student, Mr Crispian Wilson (Magdalen College), was placed in the top 10%.

The Royal College of Ophthalmology advise that the standard of the exam is deliberately high and those students taking the top places are to be congratulated. The names of students gaining a top 20 place are published and the candidate gaining the highest mark is offered the chance to visit St John’s Eye Hospital in Jerusalem or a monetary prize of £400. 

Questions are mostly based on clinical ophthalmology but other areas covered include ocular physiology, anatomy and pathology as well as genetics of eye conditions and socio-economic medicine relevant to ophthalmology  (for example, blind registration or world blindness).  In the clinical questions all the sub-speciality areas within ophthalmology are covered. 

Similar stories

New reporting guidelines developed to improve AI in healthcare settings

New reporting guidelines, jointly published in Nature Medicine and the BMJ by Oxford researchers, will ensure that early studies on using Artificial Intelligence (AI) to treat real patients will give researchers the information needed to develop AI systems safely and effectively.

Major boost for Oxford’s mission to counter future pandemic threats

The Moh Family Foundation has given a substantial gift to support the work of Oxford University’s Pandemic Sciences Institute, greatly strengthening its ability to identify and counter future pandemic threats and ensure equitable access to treatments and vaccines around the world.

Three NHSBT research units launch at University of Oxford

The NIHR has awarded three new Blood and Transplant Research Units (BTRUs) to the University of Oxford.

Fourth COVID-19 vaccine dose provides stronger immunity boost than third dose, shows UK study

COVID-19 vaccines given as fourth doses in the UK offer excellent boosting immunity protection, according to the latest results from a nationwide NIHR-supported study.

COVID-19’s high blood clot risk

A recent study of patient health records found that around 1 in 100 people with COVID-19 had a venal or arterial thrombosis, with rates higher still among males, and particularly for those hospitalised.

Medical Sciences Division receives REF 2021 results

Today the UK Funding Bodies have published the outcomes of the recent national research assessment exercise, the Research Excellence Framework (REF) 2021. REF is the UK-wide assessment of research in universities, and provides an expert evaluation of the quality of the research outputs, impact and environment at subject level in each university.